Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T19:02:11.294Z.
Calculation as of: 2026-10-06T19:02:11.294Z.
Quote observation: 2026-10-06T19:00:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 97f82c903e8e6ec217280dce7f3fe4a68629f44b5a27270464b7740b55d93be6
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Market Cap
$358.14M
EV/EBITDA Ratio
N/A
TTM Avg
40.38x
3Y Avg
40.38x
5Y Avg
40.38x
Market Cap
$357.88M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$357.26M
EV/EBITDA Ratio
6.53x
TTM Avg
7.04x
3Y Avg
7.63x
5Y Avg
8.90x
Market Cap
$357.08M
EV/EBITDA Ratio
N/A
TTM Avg
37.95x
3Y Avg
29.61x
5Y Avg
22.14x
Market Cap
$376.01M
EV/EBITDA Ratio
N/A
TTM Avg
682.46x
3Y Avg
682.46x
5Y Avg
682.46x
Market Cap
$378.31M
EV/EBITDA Ratio
N/A
TTM Avg
10.71x
3Y Avg
10.71x
5Y Avg
10.71x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Opus Genetics, Inc. (IRD) | $366.25M | N/A | N/A | N/A | N/A |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $358.14M | N/A | 40.38x | 40.38x | 40.38x |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $357.88M | N/A | N/A | N/A | N/A |
| Ocugen, Inc. (OCGN)vs › | $357.76M | N/A | N/A | N/A | N/A |
| Embecta Corp. (EMBC)vs › | $357.32M | 5.39x | 4.73x | 7.57x | 7.31x |
| Viemed Healthcare, Inc. (VMD)vs › | $357.26M | 6.53x | 7.04x | 7.63x | 8.90x |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $357.08M | N/A | 37.95x | 29.61x | 22.14x |
| Canopy Growth Corporation (CGC)vs › | $376.01M | N/A | 682.46x | 682.46x | 682.46x |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $378.31M | N/A | 10.71x | 10.71x | 10.71x |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $377.77M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
